公开(公告)号：US20200000867A1

公开(公告)日：2020-01-02

申请号：US16567512

申请日：2019-09-11

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Young-Gyu Kang ,  Soo Hyun Kim ,  Chan Woong Park ,  Hee Young Jeon

IPC: A61K36/48 ,  A61Q19/00 ,  A61P21/00 ,  A61K8/96

Abstract: The present invention relates to a composition for inhibiting and preventing myopathy comprising a bean leaf extract as an active ingredient. More specifically, the composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.

公开(公告)号：US10898535B2

公开(公告)日：2021-01-26

申请号：US16567512

申请日：2019-09-11

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Young-Gyu Kang ,  Soo Hyun Kim ,  Chan Woong Park ,  Hee Young Jeon

IPC: A61K36/48 ,  A61Q19/00 ,  A61K8/9789 ,  A61P21/00 ,  A61K8/96

Abstract: The present invention relates to a composition for inhibiting and preventing myopathy comprising a bean leaf extract as an active ingredient. More specifically, the composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.